⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 2, 2026Diabetes & Metabolism

Overview of the major clinical trials investigating stem cells–based therapies for diabetes

Tzu-Min Lin Tzu-Ching Lin Cheng-Han Lin Chih-Sheng Lin Chih-Sheng Lin Chih-Sheng Lin

View at Publisher

Ask AI

Bookmark

Share

Key Points

Stem cell therapies may enhance insulin production in diabetes, leading to better disease management.
Multiple clinical trials demonstrate varying degrees of success with beta cell regeneration, particularly in Type 1 diabetes.
Evaluation of clinical trial data across different interventions has been conducted to identify optimal protocols for treatment.
Findings underscore the need for further research to validate these therapies in diverse diabetes populations.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Overview highlights stem cell therapies' potential to improve treatment outcomes in diabetes populations, suggesting significant benefits.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lin et al. (2026) studied this question.

synapsesocial.com/papers/69a76653badf0bb9e87dc928 https://doi.org/10.1016/j.diabet.2026.101738

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE studyDiabetes & Metabolism · 2026
2Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA StudyDiabetes & Metabolism · 2026
3Blood oxygen saturation and its associations with autonomic and peripheral neuropathy in diabetesDiabetes & Metabolism · 2026
4Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease - the ACTIDIANE randomized controlled trialDiabetes & Metabolism · 2026
5Risk stratification of MASLD-related advanced fibrosis using a novel point-of-care device: the HepatoscopeDiabetes & Metabolism · 2026

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostinDiabetes & Metabolism · 2026
Advanced automated insulin delivery in inpatients receiving nutritional support: a single-center, open-label, randomised controlled trialDiabetes & Metabolism · 2026
Decoding the exposome for type 1 diabetes prevention: A scoping review of environmental determinantsDiabetes & Metabolism · 2026
Comparative review of the pharmacokinetics and pharmacodynamics of testosterone therapies in type 2 diabetesDiabetes & Metabolism · 2026
Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC)Diabetes & Metabolism · 2026

More from Diabetes & Metabolism

More from National Yang Ming Chiao Tung University

More from Koo Foundation Sun Yat-Sen Cancer Center

More from Institute for Information Industry